| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.0M | -49.6% |
| R&D Expense | $12.4M | -7.3% |
| SG&A Expense | $12.2M | -1.2% |
| Operating Income | -$22.5M | -4.1% |
| Interest Expense | $15K | +25.0% |
| Pre-tax Income | -$24.9M | -41.2% |
| Income Tax | $200K | +73.9% |
| Net Income | -$19.2M | -47.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.1M | -9.6% |
| Accounts Receivable | $173K | +203.5% |
| Current Assets | $27.1M | +73.4% |
| Total Assets | $33.2M | +30.5% |
| Current Liabilities | $7.7M | -9.3% |
| Total Liabilities | $27.4M | +167.3% |
| Stockholders' Equity | -$10.7M | -10.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.0M | +17.0% |
| Capital Expenditures | $21K | — |
| Investing Cash Flow | -$21K | — |
| Financing Cash Flow | $14.8M | -45.3% |
| Free Cash Flow | -$16.0M | +16.9% |